TY - JOUR
T1 - Syntaxin 11 is required for NK and CD8+ T-cell cytotoxicity and neutrophil degranulation
AU - D'Orlando, Orietta
AU - Zhao, Fang
AU - Kasper, Brigitte
AU - Orinska, Zane
AU - Müller, Jürgen
AU - Hermans-Borgmeyer, Irm
AU - Griffiths, Gillian M.
AU - Zur Stadt, Udo
AU - Bulfone-Paus, Silvia
PY - 2013/1
Y1 - 2013/1
N2 - Syntaxin 11 (STX11) controls vesicular trafficking and is a key player in exocytosis. Since Stx11 mutations are causally associated with a familial hemophagocytic lymphohistio-cytosis, we wanted to clarify whether STX11 is functionally important for key immune cell populations. This was studied in primary cells obtained from newly generated Stx11-/- mice. Our data revealed that STX11 is not only widely expressed in different immune cells, but also induced upon LPS or IFN-γ treatment. However, Stx11 deficiency does not affect macrophage phagocytic function and cytokine secretion, mast cell activation, or antigen presentation by DCs. Instead, STX11 selectively controls lymphocyte cytotoxicity in NK and activated CD8+ T cells and degranulation in neutrophils. Stx11-/- NK cells and CTLs show impaired degranulation, despite a comparable activation, maturation and expression of the complex-forming partners MUNC18-2 and VTI1B. In addition, Stx11-/- CTLs and NK cells produce abnormal levels of IFN-γ. Since functional reconstitution rescues the defective phenotype of Stx11-/- CTLs, we suggest a direct, specific and key role of STX11 in controlling lymphocyte cytotoxicity, cytokine production and secretion. Finally, we show that these mice are a very useful tool for dissecting the role of STX11 in vesicular trafficking and secretion.
AB - Syntaxin 11 (STX11) controls vesicular trafficking and is a key player in exocytosis. Since Stx11 mutations are causally associated with a familial hemophagocytic lymphohistio-cytosis, we wanted to clarify whether STX11 is functionally important for key immune cell populations. This was studied in primary cells obtained from newly generated Stx11-/- mice. Our data revealed that STX11 is not only widely expressed in different immune cells, but also induced upon LPS or IFN-γ treatment. However, Stx11 deficiency does not affect macrophage phagocytic function and cytokine secretion, mast cell activation, or antigen presentation by DCs. Instead, STX11 selectively controls lymphocyte cytotoxicity in NK and activated CD8+ T cells and degranulation in neutrophils. Stx11-/- NK cells and CTLs show impaired degranulation, despite a comparable activation, maturation and expression of the complex-forming partners MUNC18-2 and VTI1B. In addition, Stx11-/- CTLs and NK cells produce abnormal levels of IFN-γ. Since functional reconstitution rescues the defective phenotype of Stx11-/- CTLs, we suggest a direct, specific and key role of STX11 in controlling lymphocyte cytotoxicity, cytokine production and secretion. Finally, we show that these mice are a very useful tool for dissecting the role of STX11 in vesicular trafficking and secretion.
KW - CTL
KW - Cytokines
KW - Exocytosis
KW - N-ethylmaleimide-sensitive factor attachment protein receptor
UR - http://www.scopus.com/inward/record.url?scp=84872473670&partnerID=8YFLogxK
U2 - 10.1002/eji.201142343
DO - 10.1002/eji.201142343
M3 - Article
C2 - 23042080
AN - SCOPUS:84872473670
SN - 0014-2980
VL - 43
SP - 194
EP - 208
JO - European Journal of Immunology
JF - European Journal of Immunology
IS - 1
ER -